News
Search EMA's news announcements
Injectable lenacapavir, administered twice yearly, is highly effective at preventing HIV
Aqneursa significantly improves neurological signs, symptoms and functioning
Vaccine to be used only when there is a significant chikungunya risk and after careful consideration of the benefits and risks
Sabine Scherer begins her three-year mandate in September 2025
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting
Ixchiq: temporary restriction on vaccinating people 65 years and older to be lifted
Vaccine to be used only when there is a significant chikungunya risk and after careful consideration of the benefits and risks
EMA and HMA recommendations to address vulnerabilities in the supply of critical medicines used during pregnancy
Review will evaluate effectiveness in treating alcohol withdrawal syndrome and supporting abstinence, as well as measures to mitigate risk of abuse
13 new medicines recommended for approval; another six medicines recommended for extension of their therapeutic indications